Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cost-Effectiveness Analysis of Direct-Acting Antiviral Agents for Occupational Hepatitis C Infections in Germany.

Runge M, Krensel M, Westermann C, Bindl D, Nagels K, Augustin M, Nienhaus A.

Int J Environ Res Public Health. 2020 Jan 9;17(2). pii: E440. doi: 10.3390/ijerph17020440.

2.

Cost of illness in Charcot-Marie-Tooth neuropathy: Results from Germany.

Schorling E, Thiele S, Gumbert L, Krause S, Klug C, Schreiber-Katz O, Reilich P, Nagels K, Walter MC.

Neurology. 2019 Apr 23;92(17):e2027-e2037. doi: 10.1212/WNL.0000000000007376. Epub 2019 Mar 27. Erratum in: Neurology. 2019 Aug 27;93(9):415.

PMID:
30918088
3.

Economic data for particle therapy: Dealing with different needs in a heterogeneous landscape.

Lievens Y, Nagels K.

Radiother Oncol. 2018 Jul;128(1):19-25. doi: 10.1016/j.radonc.2018.03.016. Epub 2018 Mar 29. Review.

PMID:
29606525
4.

Disease burden of spinal muscular atrophy in Germany.

Klug C, Schreiber-Katz O, Thiele S, Schorling E, Zowe J, Reilich P, Walter MC, Nagels KH.

Orphanet J Rare Dis. 2016 May 4;11(1):58. doi: 10.1186/s13023-016-0424-0.

5.

First outline and baseline data of a randomized, controlled multicenter trial to evaluate the health economic impact of home telemonitoring in chronic heart failure - CardioBBEAT.

Hofmann R, Völler H, Nagels K, Bindl D, Vettorazzi E, Dittmar R, Wohlgemuth W, Neumann T, Störk S, Bruder O, Wegscheider K, Nagel E, Fleck E; CardioBBEAT Investigators.

Trials. 2015 Aug 11;16:343. doi: 10.1186/s13063-015-0886-8.

6.

Comparative cost of illness analysis and assessment of health care burden of Duchenne and Becker muscular dystrophies in Germany.

Schreiber-Katz O, Klug C, Thiele S, Schorling E, Zowe J, Reilich P, Nagels KH, Walter MC.

Orphanet J Rare Dis. 2014 Dec 18;9:210. doi: 10.1186/s13023-014-0210-9.

Supplemental Content

Loading ...
Support Center